DL-Alanine-13C2(Synonyms: DL-2-Aminopropionic acid-13C2)

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
DL-Alanine-13C2 (Synonyms: DL-2-Aminopropionic acid-13C2)

DL-Alanine-13C2 是一种 13C 标记的 DL-Alanine。DL-alanine 是一种氨基酸，是L-和D-丙氨酸的外消旋化合物。DL-alanine 与硝酸银水溶液一起用于纳米颗粒生成，作为还原剂和封端剂。DL-alanine 可用于 Cu(II)、Zn(II)、Cd(11) 等过渡金属螯合的研究。DL-alanine 是一种甜味剂，与甘氨酸和糖精钠归为一类。DL-alanine 在组织和肝脏之间的葡萄糖-丙氨酸循环中起关键作用[2]

DL-Alanine-13C2(Synonyms: DL-2-Aminopropionic acid-13C2)

DL-Alanine-13C2 Chemical Structure

CAS No. : 70753-82-1

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

DL-Alanine-13C2 (DL-2-Aminopropionic acid-13C2) is the 13C-labeled DL-Alanine. DL-alanine, an amino acid, is the racemic compound of L- and D-alanine. DL-alanine is employed both as a reducing and a capping agent, used with silver nitrate aqueous solutions for the production of nanoparticles. DL-alanine can be used for the research of transition metals chelation, such as Cu(II), Zn(II), Cd(11). DL-alanine, a sweetener, is classed together with glycine, and sodium saccharin. DL-alanine plays a key role in the glucose-alanine cycle between tissues and liver[1][2][3][4][5][6].

体外研究
(In Vitro)

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

91.08

Formula

C13C2H7NO2
CAS 号

70753-82-1
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.

    [2]. Yamaguchi M, et al. Terahertz absorption spectra of L-, D-, and DL-alanine and their application to determination of enantiometric composition[J]. Applied Physics Letters, 2005, 86(5): 053903.

    [3]. Eder José Guidelli, et, al. Synthesis of silver nanoparticles using dl-alanine for ESR dosimetry applications. Radiation Physics and Chemistry. Volume 81, Issue 3, 2012: Pages 301-307.

    [4]. Yamaguchi M, et al. Terahertz absorption spectra of L-, D-, and DL-alanine and their application to determination of enantiometric composition[J]. Applied Physics Letters, 2005, 86(5): 053903.

    [5]. Yamaguchi M, et al. Terahertz absorption spectra of L-, D-, and DL-alanine and their application to determination of enantiometric composition[J]. Applied Physics Letters, 2005, 86(5): 053903.

    [6]. Yamaguchi M, et al. Terahertz absorption spectra of L-, D-, and DL-alanine and their application to determination of enantiometric composition[J]. Applied Physics Letters, 2005, 86(5): 053903.

    [7]. Amrallah AH, et al. Mixed ligand complexes of benzimidazole and pyrimidine hydroxy azo dyes with some transition metals and glycine, dl-alanine or dl-leucine. Talanta. 1998 Aug;46(4):491-500.

    [8]. Eder José Guidelli, et, al. Synthesis of silver nanoparticles using dl-alanine for ESR dosimetry applications. Radiation Physics and Chemistry. Volume 81, Issue 3, 2012: Pages 301-307.

    [9]. Eder José Guidelli, et, al. Synthesis of silver nanoparticles using dl-alanine for ESR dosimetry applications. Radiation Physics and Chemistry. Volume 81, Issue 3, 2012: Pages 301-307.

    [10]. Eder José Guidelli, et, al. Synthesis of silver nanoparticles using dl-alanine for ESR dosimetry applications. Radiation Physics and Chemistry. Volume 81, Issue 3, 2012: Pages 301-307.

    [11]. Yamamoto T, et al. Gustatory reaction time to various sweeteners in human adults. Physiol Behav. 1985 Sep;35(3):411-5.

    [12]. Amrallah AH, et al. Mixed ligand complexes of benzimidazole and pyrimidine hydroxy azo dyes with some transition metals and glycine, dl-alanine or dl-leucine. Talanta. 1998 Aug;46(4):491-500.

    [13]. Amrallah AH, et al. Mixed ligand complexes of benzimidazole and pyrimidine hydroxy azo dyes with some transition metals and glycine, dl-alanine or dl-leucine. Talanta. 1998 Aug;46(4):491-500.

    [14]. Amrallah AH, et al. Mixed ligand complexes of benzimidazole and pyrimidine hydroxy azo dyes with some transition metals and glycine, dl-alanine or dl-leucine. Talanta. 1998 Aug;46(4):491-500.

    [15]. Rashid M, et al. Biosynthesis of Self-Dispersed Silver Colloidal Particles Using the Aqueous Extract of P. peruviana for Sensing dl-Alanine[J]. Isrn Nanotechnology, 2014, 2014:1-7.

    [16]. Yamamoto T, et al. Gustatory reaction time to various sweeteners in human adults. Physiol Behav. 1985 Sep;35(3):411-5.

    [17]. Yamamoto T, et al. Gustatory reaction time to various sweeteners in human adults. Physiol Behav. 1985 Sep;35(3):411-5.

    [18]. Yamamoto T, et al. Gustatory reaction time to various sweeteners in human adults. Physiol Behav. 1985 Sep;35(3):411-5.

    [19]. Tapper DN, et al. Taste stimuli: a behavioral categorization. Science. 1968 Aug 16;161(3842):708-10.

    [20]. Rashid M, et al. Biosynthesis of Self-Dispersed Silver Colloidal Particles Using the Aqueous Extract of P. peruviana for Sensing dl-Alanine[J]. Isrn Nanotechnology, 2014, 2014:1-7.

    [21]. Rashid M, et al. Biosynthesis of Self-Dispersed Silver Colloidal Particles Using the Aqueous Extract of P. peruviana for Sensing dl-Alanine[J]. Isrn Nanotechnology, 2014, 2014:1-7.

    [22]. Rashid M, et al. Biosynthesis of Self-Dispersed Silver Colloidal Particles Using the Aqueous Extract of P. peruviana for Sensing dl-Alanine[J]. Isrn Nanotechnology, 2014, 2014:1-7.

    [23]. Tapper DN, et al. Taste stimuli: a behavioral categorization. Science. 1968 Aug 16;161(3842):708-10.

    [24]. Tapper DN, et al. Taste stimuli: a behavioral categorization. Science. 1968 Aug 16;161(3842):708-10.

    [25]. Tapper DN, et al. Taste stimuli: a behavioral categorization. Science. 1968 Aug 16;161(3842):708-10.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务